Cellectar Biosciences, Inc.
CLRB
$3.17
-$0.09-2.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.30M | -4.44M | -5.45M | -6.60M | -2.36M |
| Total Depreciation and Amortization | 49.50K | 52.30K | 55.60K | 56.30K | 68.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 290.10K | 292.90K | 82.50K | 920.70K | -8.56M |
| Change in Net Operating Assets | 611.50K | -176.40K | 194.40K | -3.76M | -63.60K |
| Cash from Operations | -4.34M | -4.28M | -5.12M | -9.38M | -10.91M |
| Capital Expenditure | -5.90K | -- | -- | -- | -61.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.90K | -- | -- | -- | -61.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.99M | 5.79M | 2.25M | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.99M | 5.79M | 2.25M | -- | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 641.70K | 1.51M | -2.86M | -9.38M | -10.97M |